España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
NeoGenomics
NEO
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.80
-0.13
-0.87%
Last update: 9:30 AM
15 minutes delayed
Get Report
Comment
Q2 2024 Earnings in 5 days from now on Mon Jul 29th, after the market close
Conference call scheduled in 5 days at 16:30 PM
Click to view the webcast
NeoGenomics (NEO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for NeoGenomics (NASDAQ:NEO) Stock
NeoGenomics Stock (NASDAQ: NEO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, May 28, 2024
NeoGenomics Introduces Comprehensive Lung Sol...
Benzinga Newsdesk
Friday, May 10, 2024
NeoGenomics Earnings Analysis: Q1 Recap
Benzinga Insights
Thursday, May 02, 2024
BTIG Maintains Buy on NeoGenomics, Lowers Pri...
Benzinga Newsdesk
Wednesday, May 01, 2024
TD Cowen Maintains Buy on NeoGenomics, Lowers...
Benzinga Newsdesk
Craig-Hallum Assumes NeoGenomics at Buy, Anno...
Benzinga Newsdesk
Benchmark Reiterates Buy on NeoGenomics, Main...
Benzinga Newsdesk
Tuesday, April 30, 2024
Where NeoGenomics Stands With Analysts
Benzinga Insights
Needham Maintains Buy on NeoGenomics, Lowers ...
Benzinga Newsdesk
NeoGenomics shares are trading lower. The com...
Benzinga Newsdesk
CORRECTION: NeoGenomics Ticker Is NEO
Benzinga Newsdesk
NeoGenomics Sees Fy24 Revenue Of $650M - $660...
Benzinga Newsdesk
NeoGenomics Q1 Adj $(0.02) Beats $(0.05) Esti...
Benzinga Newsdesk
Monday, March 18, 2024
What 6 Analyst Ratings Have To Say About NeoGenomics
Benzinga Insights
Friday, March 15, 2024
Earnings Scheduled For March 15, 2024
Benzinga Insights
Monday, February 26, 2024
Piper Sandler Maintains Overweight on NeoGeno...
Benzinga Newsdesk
Thursday, February 22, 2024
Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
Benzinga Insights
Wednesday, February 21, 2024
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
Vandana Singh
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
NeoGenomics shares are trading higher after t...
Benzinga Newsdesk
Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Evaluating NeoGenomics: Insights From 4 Financial Analysts
Benzinga Insights
Needham Maintains Buy on NeoGenomics, Raises ...
Benzinga Newsdesk
Tuesday, February 20, 2024
NeoGenomics shares are trading higher after t...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
NeoGenomics Sees FY24 Adj. EPS $0.04 Vs $(0.0...
Benzinga Newsdesk
Recap: NeoGenomics Q4 Earnings
Benzinga Insights
NeoGenomics Q4 2023 Adj EPS $0.03 Beats $(0.0...
Benzinga Newsdesk
Earnings Scheduled For February 20, 2024
Benzinga Insights
Monday, February 19, 2024
NeoGenomics's Earnings Outlook
Benzinga Insights
Thursday, February 01, 2024
NeoGenomics Says It Signed For Working With C...
Benzinga Newsdesk
Friday, December 29, 2023
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
TD Cowen Maintains Outperform on NeoGenomics,...
Benzinga Newsdesk
BTIG Maintains Buy on NeoGenomics, Lowers Pri...
Benzinga Newsdesk
Thursday, December 28, 2023
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
Vandana Singh
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday
Avi Kapoor
7 Analysts Have This To Say About NeoGenomics
Benzinga Insights
Needham Reiterates Buy on NeoGenomics, Mainta...
Benzinga Newsdesk
NeoGenomics shares are trading lower after Na...
Benzinga Newsdesk
NeoGenomics Announced That Subsidiary Neogen...
Benzinga Newsdesk
Natera Wins Preliminary Injunction In Patent ...
Benzinga Newsdesk
Tuesday, December 05, 2023
NeoGenomics To Present New Data At San Antoni...
Benzinga Newsdesk
Wednesday, November 08, 2023
Morgan Stanley Maintains Equal-Weight on NeoG...
Benzinga Newsdesk
Tuesday, November 07, 2023
What 6 Analyst Ratings Have To Say About NeoGenomics
Benzinga Insights
Needham Reiterates Buy on NeoGenomics, Mainta...
Benzinga Newsdesk
Monday, November 06, 2023
NeoGenomics Q3 2023 Sales $151.95M Beat $142....
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch